Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Tattoo markers help place ear prostheses easily and improve acceptance.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Severe acne patients have higher inflammatory markers than healthy people.

Cancer survivors need better skin care to improve their quality of life.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Early balding at 40 increases prostate cancer risk.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Early lung cancer screening in Ontario reduces deaths and is cost-effective.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Suppressing certain hormones might help prevent prostate cancer.